Momentum is fast developing behind the implementation of continuous manufacturing in pharma. Many pharmaceutical companies are judging that the time is right to put major effort into its development. The tools now exist to manufacture pharmaceutical products with the high levels of process understanding and control needed for continuous throughput.
The race is on between companies to be the first to apply continuous manufacturing in commercial production. The prize for companies is considerable. Small, fully enclosed processes, with a high level of automation and reduced manual intervention, will enable companies to reduce variability, deliver high yields, increase profitability and lower operating, inventory and capital costs.